Evidence map›Paper›PMID 20019191›Full record

ArticleThe American journal of pathology2010

Human nephrosclerosis triggers a hypoxia-related glomerulopathy.

Matthias A Neusser, Maja T Lindenmeyer, Anton G Moll, Stephan Segerer, Ilka Edenhofer, Kontheari Sen, Daniel P Stiehl, Matthias Kretzler, Hermann-Josef Gröne, Detlef Schlöndorff and 1 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The American journal of pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 104 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Identification of an Altered Matrix Signature in Kidney Aging and Disease.Journal of the American Society of Nephrology : JASN · 2021
    Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Matthias A NeusserClinic and Policlinic for Internal Medicine, University Hospital Zurich, 8057 Zurich, Switzerland.
Maja T Lindenmeyer
Anton G Moll
Stephan Segerer
Ilka Edenhofer
Kontheari Sen
Daniel P Stiehl
Matthias Kretzler
Hermann-Josef Gröne
Detlef Schlöndorff
Clemens D Cohen
Swiss Integrative Center for Human Health · CHAnatomyWorks (United States) · USUniversity Hospital of Zurich · CHGerman Cancer Research Center · DEIcahn School of Medicine at Mount Sinai · USUniversity of Michigan–Ann Arbor · US

Funding

Molecular Progression Predictors in the Chronic Renal Insufficiency CohortR01DK079912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRETZLER, MATTHIAS · 2008 to 2012
$2.8M
Modulators of Kidney FibrosisR01DK081420 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHLONDORFF, DETLEF OLAF · 2008 to 2011
$1.5M
NIDDK NIH HHS R01 DK079912NIDDK NIH HHS R01 DK081420NIDDK NIH HHS R01-DK081420-01
6 · The paper itself

Abstract

In the kidney, hypoxia contributes to tubulointerstitial fibrosis, but little is known about its implications for glomerular damage and glomerulosclerosis. Chronic hypoxia was hypothesized to be involved in nephrosclerosis (NSC) or "hypertensive nephropathy." In the present study genome-wide expression data from microdissected glomeruli were studied to examine the role of hypoxia in glomerulosclerosis of human NSC. Functional annotation analysis revealed prominent regulation of hypoxia-associated biological processes in NSC, including angiogenesis, fibrosis, and inflammation. Glomerular expression levels of a majority of genes regulated by the hypoxia-inducible factors (HIFs) were significantly altered in NSC. Among these HIF targets, chemokine C-X-C motif receptor 4 (CXCR4) was prominently induced. Glomerular CXCR4 mRNA induction was confirmed by quantitative RT-PCR in an independent cohort with NSC but not in those with other glomerulopathies. By immunohistological analysis, CXCR4 showed enhanced positivity in podocytes in NSC biopsy specimens. This CXCR4 positivity was associated with nuclear localization of HIF1alpha only in podocytes of NSC, indicating transcriptional activity of HIF. As the CXCR4 ligand CXCL12/SDF-1 is constitutively expressed in podocytes, autocrine signaling may contribute to NSC. In addition, a blocking CXCR4 antibody caused significant inhibition of wound closure by podocytes in an in vitro scratch assay. These data support a role for CXCR4/CXCL12 in human NSC and indicate that hypoxia not only is involved in tubulointerstitial fibrosis but also contributes to glomerular damage in NSC.

Indexed as

AdolescentAdultAgedAnimalsCase-Control StudiesCells, CulturedFemaleGene Expression ProfilingHumansHypoxiaKidney DiseasesKidney GlomerulusMaleMiceMiddle AgedNephrosclerosisOxygen

Identifiers

PMID20019191
PMCPMC2808068
OpenAlexW2094121461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.